Antengene (HKG:6996) will buy back up to 67,488,874 shares, or 10% of the entire shareholding of the drug company, according to a Tuesday filing with the Hong Kong bourse.
The maximum aggregate price for the share repurchase is HK$40 million, the filing said.
Antengene's shares rose 1% during Tuesday's afternoon trading.